BioPharma Credit signs $400 million financing deal with Novocure
LONDON: BioPharma Credit PLC, a leading debt investment trust listed on the London Stock Exchange (LSE: BPCR), has declared a substantial financial agreement through its wholly owned subsidiary and in conjunction with BioPharma Credit Investments V (Master) LP. The partnership…